Informações:
Falhas:
ID
25447
Descrição
Study ID: 101468/166 Clinical Study ID: SKF-101468/166 Study Title: A Phase II, randomised, double-blind, active-controlled, dose-escalation study to determine the maximum well-tolerated starting dose of a new formulation of ropinirole in Parkinson's Disease patients not receiving other dopaminergic therapies Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Parkinson Disease
Palavras-chave
Versões (2)
- 16/08/2017 16/08/2017 -
- 04/09/2017 04/09/2017 -
Transferido a
4 de setembro de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
visit 1 medical history starting dose of ropinirole Parkinson's Disease 101468/166
visit 1 medical history starting dose of ropinirole Parkinson's Disease 101468/166
Similar models
visit 1 medical history starting dose of ropinirole Parkinson's Disease 101468/166
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
patient's initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
patient number
Item
Patient No.
integer
C1830427 (UMLS CUI [1])
date of visit
Item
Date of Visit
date
C1320303 (UMLS CUI [1])
date of birth
Item
Date of Birth
date
C0421451 (UMLS CUI [1])
CL Item
Male (1)
CL Item
Female (2)
CL Item
Caucasian (1)
CL Item
Black (2)
CL Item
Asian (3)
CL Item
Hispanic (4)
CL Item
Other, specify (5)
Item
GENERAL APPEARANCE & SKIN
integer
C1148438 (UMLS CUI [1])
C1123023 (UMLS CUI [2])
C1123023 (UMLS CUI [2])
CL Item
normal (1)
CL Item
abnormal (2)
general appearance and skin abnormalities
Item
GENERAL APPEARANCE & SKIN ABNORMALITY
text
C1148438 (UMLS CUI [1,1])
C1704258 (UMLS CUI [1,2])
C1123023 (UMLS CUI [2,1])
C1704258 (UMLS CUI [2,2])
C1704258 (UMLS CUI [1,2])
C1123023 (UMLS CUI [2,1])
C1704258 (UMLS CUI [2,2])
Item
HEAD, EYES, EARS, NOSE & THROAT
integer
C0018670 (UMLS CUI [1])
C0015392 (UMLS CUI [2])
C0013443 (UMLS CUI [3])
C0028429 (UMLS CUI [4])
C0031354 (UMLS CUI [5])
C0015392 (UMLS CUI [2])
C0013443 (UMLS CUI [3])
C0028429 (UMLS CUI [4])
C0031354 (UMLS CUI [5])
CL Item
normal (1)
CL Item
abnormal (2)
head, eyes, ears, nose & throat abnormalities
Item
HEAD, EYES, EARS, NOSE & THROAT ABNORMALITY
text
C0018670 (UMLS CUI [1,1])
C1704258 (UMLS CUI [1,2])
C0015392 (UMLS CUI [2,1])
C1704258 (UMLS CUI [2,2])
C0013443 (UMLS CUI [3,1])
C1704258 (UMLS CUI [3,2])
C0028429 (UMLS CUI [4,1])
C1704258 (UMLS CUI [4,2])
C0031354 (UMLS CUI [5,1])
C1704258 (UMLS CUI [5,2])
C1704258 (UMLS CUI [1,2])
C0015392 (UMLS CUI [2,1])
C1704258 (UMLS CUI [2,2])
C0013443 (UMLS CUI [3,1])
C1704258 (UMLS CUI [3,2])
C0028429 (UMLS CUI [4,1])
C1704258 (UMLS CUI [4,2])
C0031354 (UMLS CUI [5,1])
C1704258 (UMLS CUI [5,2])
CL Item
normal (1)
CL Item
abnormal (2)
cardiovascular abnormalities
Item
CARDIOVASCULAR ABNORMALITY
text
C0243050 (UMLS CUI [1])
CL Item
normal (1)
CL Item
abnormal (2)
respiratory disorders
Item
RESPIRATORY ABNORMALITY
text
C0035204 (UMLS CUI [1])
CL Item
normal (1)
CL Item
abnormal (2)
gastrointestinal disorders
Item
ABDOMINAL& GASTROINTESTINAL ABNORMALITY
text
C0017178 (UMLS CUI [1])
CL Item
normal (1)
CL Item
abnormal (2)
musculoskeletal disorders
Item
MUSCULOSKELETAL ABNORMALITY
text
C0026857 (UMLS CUI [1])
CL Item
normal (1)
CL Item
abnormal (2)
neurological disorders
Item
NEUROLOGIC ABNORMALITY
text
C0027765 (UMLS CUI [1])
CL Item
normal (1)
CL Item
abnormal (2)
genitourinary disorder
Item
GENITOURINARY ABNORMALITY
text
C0080276 (UMLS CUI [1])
Item
HEMATOPOIETIC& LYMPHATIC
integer
C0018957 (UMLS CUI [1])
C0024235 (UMLS CUI [2])
C0024235 (UMLS CUI [2])
CL Item
normal (1)
CL Item
abnormal (2)
hematopoetic disorders and lymphatic disorders
Item
HEMATOPOIETIC& LYMPHATIC ABNORMALITY
text
C0024228 (UMLS CUI [1])
CL Item
normal (1)
CL Item
abnormal (2)
endocrine system disorders
Item
ENDOCRINE & METABOLIC ABNORMALITY
text
C0014130 (UMLS CUI [1])
CL Item
normal (1)
CL Item
abnormal (2)
Item
OTHER ASPECTS ABNORMALITY
text
C0205394 (UMLS CUI [1,1])
C1704258 (UMLS CUI [1,2])
C1704258 (UMLS CUI [1,2])
Item
Surgical Procedures related to Parkinson's Disease
integer
C0543467 (UMLS CUI [1,1])
C0030567 (UMLS CUI [1,2])
C0030567 (UMLS CUI [1,2])
Code List
Surgical Procedures related to Parkinson's Disease
CL Item
Yes (1)
CL Item
No (2)
date of surgical procedure
Item
Date of Surgical Procedure
date
C0543467 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
type of surgical procedure
Item
Type of Surgical Procedure
text
C0543467 (UMLS CUI [1])
CL Item
Yes (1)
CL Item
No (2)
allergen
Item
Allergen
text
C0002092 (UMLS CUI [1])
reaction to allergen
Item
Reaction
text
C0205332 (UMLS CUI [1,1])
C0002092 (UMLS CUI [1,2])
C0002092 (UMLS CUI [1,2])
Item Group
DURATION OF PARKINSON'S DISEASE
C0449238 (UMLS CUI-1)
C0030567 (UMLS CUI-2)
C0030567 (UMLS CUI-2)
date of onset of symptoms of Parkinson's disease
Item
Date of Onset of Symptoms of Parkinson's disease
date
C0011008 (UMLS CUI [1,1])
C1320528 (UMLS CUI [1,2])
C0030567 (UMLS CUI [1,3])
C1320528 (UMLS CUI [1,2])
C0030567 (UMLS CUI [1,3])
Hoehn-Yahr Stage
Item
HOEHN & YAHR STAGE
integer
C0451215 (UMLS CUI [1])
epworth sleepiness scale questionnaire
Item
EPWORTH SLEEP SCALE
integer
C3541276 (UMLS CUI [1])